Detalhe da pesquisa
1.
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
PLoS Med
; 19(11): e1004037, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413551
2.
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
PLoS Med
; 19(9): e1003992, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048766
3.
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study.
Eur J Clin Microbiol Infect Dis
; 41(12): 1473-1477, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282341
4.
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022.
Euro Surveill
; 27(30)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904059
5.
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
PLoS Med
; 18(12): e1003874, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919548
6.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Influenza Other Respir Viruses
; 17(11): e13195, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019704
7.
[COVID-19 among children and adolescents].
Ugeskr Laeger
; 184(9)2022 02 28.
Artigo
em Da
| MEDLINE | ID: mdl-35244020